EyeGate Pharma Enrolls First Patient in Follow-on PE Pilot Study
Go back to EyeGate Pharma Enrolls First Patient in Follow-on PE Pilot Study| (NASDAQ: EYEG) | Delayed: 35.27 -0.02 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.29 | 52 Week High | $5.09 | |||
| Open | $35.27 | 52 Week Low | $1.11 | |||
| Day High | $35.27 | P/E | N/A | |||
| Day Low | $35.27 | EPS | $0.00 | |||
| Volume | 59 | |||||
